#
Fulcrum Announces Initiation of Phase 2b Clinical Trial of Losmapimod
Aug 19, 2019
Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD.
#
Progress Update: Optimizing the Utility of the National Registry for FSHD Research and Trial Recruitment
Aug 5, 2019
Dr. Tawil provides an update on year three of his project to get genetic testing performed for those in the registry who do not have it, and thus create a larger viable pool for upcoming clinical trials.
#
Progress Update: Young Investigator Travel Grants
Aug 2, 2019
Travel reports from recipients of travel grants for the 2019 FSH Society International Research Congress.
#
Progress Update: Aberrant Protein Synthesis
Aug 1, 2019
Sujatha Jagannathan provides a brief final summary of work on her research.
#
Progress Update: Omics Approach to Identifying Biomarkers
Aug 1, 2019
Yi-Wen Chen provides a final summary of her research activities.
#
Progress Update: CTRN International Sites
Aug 1, 2019
Dr. Tawil provides a brief update on the two CTRN European sites funded.